SEC Form DEF 14A filed by Amicus Therapeutics Inc.
$FOLD
Biotechnology: Pharmaceutical Preparations
Health Care
Unavailable
Unavailable
Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/13/2024 | $17.00 → $12.00 | Overweight → Equal-Weight | Morgan Stanley |
9/6/2024 | $18.00 | Buy | Jefferies |
5/30/2024 | $18.00 | Overweight | Wells Fargo |
5/14/2024 | $13.00 | Neutral → Buy | Guggenheim |
12/19/2023 | $15.00 → $20.00 | Equal-Weight → Overweight | Morgan Stanley |
9/9/2022 | $14.00 | Equal-Weight | Morgan Stanley |
4/13/2022 | $11.00 | Neutral | Goldman |
2/24/2022 | $16.00 → $14.00 | Outperform | SVB Leerink |